Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats

被引:28
作者
Body, S [1 ]
Kheramin, S [1 ]
Mobini, S [1 ]
Ho, MY [1 ]
Velazquez-Martinez, DN [1 ]
Bradshaw, CM [1 ]
Szabadi, E [1 ]
机构
[1] Univ Nottingham, Psychopharmacol Sect, Div Psychiat, Med Sch,Queens Med Ctr, Nottingham NG7 2UH, England
来源
BEHAVIOURAL PHARMACOLOGY | 2002年 / 13卷 / 08期
关键词
8-OH-DPAT; WAY-100635; timing; free-operant psychophysical procedure; 5,7-dihydroxytryptamine; 5-HT1A receptors; rat;
D O I
10.1097/00008877-200212000-00001
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In this experiment we examined the effect of a serotonin receptor (5-HT1A) agonist and antagonist WAY-100635 (N-12-(4-12-methoxy-phenyl]-1-piperazinyl)ethyl]-N-2-pyridinylcyclohexane-carboxamide) on temporal differentiation, in intact rats and rats whose serotonergic (5-HTergic) pathways had been destroyed by 5,7-dihydroxytryptamine (5,7-DHT). Thirteen rats received 5,7-DHT-induced lesions of the median and dorsal raphe nuclei; 14 rats received sham lesions. They were trained to press two levers (A and B) in 50-s trials, in which reinforcement was contingent upon responding on A in the first half, and B in the second half, of the trial. Logistic psychophysical curves were fitted to the relative response rate data (percent responding on B, %B), for derivation of timing indices [T-50 (time corresponding to %B = 50%), slope, Weber fraction] following WAY-100635, 8-OH-DPAT 18-hydroxy-2-(di-n-propylamino)tetralin], combinations of WAY-100635+8-OH-DPAT, and vehicle alone. WAY-100635 (30, 100 and 300 mug/kg, s.c.) did not affect the timing indices. 8-OH-DPAT (100, 200 mug/kg, s.c.) reduced T-50 without affecting the Weber fraction. WAY-100635 (300 mug/kg) abolished the effect of 8-OH-DPAT on T-50 in both the lesioned and sham-lesioned groups. 5-HT levels in the neocortex, hippocampus, amygdala, nucleus accumbens and hypothalamus of the lesioned group were <20% of those in the sham-lesioned group; catecholamine levels were unaffected. The results confirm that 8-OH-DPAT disrupts temporal differentiation in a free-operant psychophysical schedule, reducing T-50, and indicate that this effect of 8-OH-DPAT is mediated by postsynaptic 5-HT1A receptors. (C) 2002 Lippincott Williams & Wilkins.
引用
收藏
页码:603 / 614
页数:12
相关论文
共 50 条
[1]  
ALRUWAITEA ASA, 1997, TIME BEHAV PSYCHOL N
[2]   Effect of destruction of the 5-hydroxytryptaminergic pathways on behavioural timing and ''switching'' in a free operant psychophysical procedure [J].
AlZahrani, SSA ;
Ho, MY ;
Martinez, DNV ;
Cabrera, ML ;
Bradshaw, CM ;
Szabadi, E .
PSYCHOPHARMACOLOGY, 1996, 127 (04) :346-352
[3]   [3H]-8-OH-DPAT binding in the rat brain raphe area:: involvement of 5-HT1A and non-5-HT1A receptors [J].
Assié, MB ;
Koek, W .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (06) :1348-1352
[4]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[5]   DIRECT EVIDENCE FOR AN IMPORTANT SPECIES-DIFFERENCE IN THE MECHANISM OF 8-OH-DPAT-INDUCED HYPOTHERMIA [J].
BILL, DJ ;
KNIGHT, M ;
FORSTER, EA ;
FLETCHER, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (04) :1857-1864
[6]   THE BEHAVIORAL-THEORY OF TIMING - REINFORCER RATE DETERMINES PACEMAKER RATE [J].
BIZO, LA ;
WHITE, KG .
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 1994, 61 (01) :19-33
[7]   PACEMAKER RATE IN THE BEHAVIORAL-THEORY OF TIMING [J].
BIZO, LA ;
WHITE, KG .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-ANIMAL BEHAVIOR PROCESSES, 1994, 20 (03) :308-321
[8]   Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion [J].
Body, S ;
Chiang, TJ ;
Mobini, S ;
Ho, MY ;
Bradshaw, CM ;
Szabadi, E .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :787-793
[9]  
Body S, 2001, PSYCHOPHARMACOLOGY, V158, P305
[10]   ALPHA-2-ADRENOCEPTOR SUBTYPES AND IMIDAZOLINE-LIKE BINDING-SITES IN THE RAT-BRAIN [J].
BROWN, CM ;
MACKINNON, AC ;
MCGRATH, JC ;
SPEDDING, M ;
KILPATRICK, AT .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (04) :803-809